Science & Enterprise subscription

Follow us on Twitter

  • A chain of primary care clinics in grocery stores is adding diagnostics using artificial intelligence to detect an… https://t.co/ve8PhyiwCH
    about 8 hours ago
  • New post on Science and Enterprise: Retail Clinics Offer A.I.-Enabled Eye Diagnostics https://t.co/OoUw9SSz1j #Science #Business
    about 8 hours ago
  • Early results from a clinical trial testing gene editing treatments for inherited blood disorders show the treatmen… https://t.co/jw4aoZftdj
    about 12 hours ago
  • New post on Science and Enterprise: First Blood Disorder Crispr Treatments Reported https://t.co/xWaVPYOeQy #Science #Business
    about 13 hours ago
  • A group of academic, foundation, and business organizations are collaborating on the use of artificial intelligence… https://t.co/lcTk1VejUW
    about 1 day ago

Please share Science & Enterprise

Bristol-Myers Squibb Sponsoring Cancer Research Network

T cell, in blue, a key component in the body's immune system (Lawrence Berkeley National Lab)

T cell, in blue, a key component in the body's immune system (Lawrence Berkeley National Lab)

Bristol-Myers Squibb Co., a pharmaceutical company in Princeton, New Jersey, has a new collaboration with academic researchers that aims to better understand the science of immuno-oncology, the harnessing of the body’s immune system to fight cancer. The network includes researchers from 10 universities and research institutes in the U.S. and Europe.

The company says its approach to immuno-oncology focuses on using the intelligence of the immune response to seek control of tumors. Understanding how the immune system detects and reacts to cancer cells, and how tumors can evade the immune response, says Bristol-Myers Squibb, is important in developing strategies to enhance the immune system’s ability to fight cancer.

Participating institutions in the Bristol-Myers Squibb network include:

– Clinica Universidad Navarra, Pamplona, Spain

– Dana-Farber Cancer Institute, Boston, Mass.

– Earle A. Chiles Research Institute (Providence Health & Services), Portland, Oregon

– Institut Gustave Roussy, Villejuif, France

– Istituto Nazionale per lo Studio e la Cura dei Tumori, Fondazione G. Pascale, Naples, Italy

– Johns Hopkins Kimmel Cancer Center, Baltimore Maryland

– Memorial Sloan-Kettering Cancer Center, New York, New York

– Netherlands Cancer Institute, Amsterdam, Netherlands

– Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, London, U.K.

– University of Chicago, Chicago, Illinois

Bristol-Myers Squibb says it is exploring a variety of compounds and immunotherapeutic approaches for patients with different types of cancer. One objective of the collaboration is to encourage the translation of scientific research findings into clinical trials and, eventually, clinical practice. The company did not disclose financial or intellectual property details of the relationship with the institutions.

Read more:

*     *     *

Please share Science & Enterprise ...
error

1 comment to Bristol-Myers Squibb Sponsoring Cancer Research Network